Download PDF
Suchttherapie 2017; 18(02): 98-104
DOI: 10.1055/s-0042-109761
Originalarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Einstellungsscreening zum pharmakologischen Neuroenhancement bei Studierenden

Screening of Students’ Attitudes Towards Pharmacological Neuroenhancement
Thomas Ganz
1   Fakultät Soziale Arbeit, Gesundheit und Pflege, Hochschule Esslingen – University of Applied Sciences, Esslingen
,
Michael Braun
1   Fakultät Soziale Arbeit, Gesundheit und Pflege, Hochschule Esslingen – University of Applied Sciences, Esslingen
,
Marion Laging
1   Fakultät Soziale Arbeit, Gesundheit und Pflege, Hochschule Esslingen – University of Applied Sciences, Esslingen
,
Thomas Heidenreich
1   Fakultät Soziale Arbeit, Gesundheit und Pflege, Hochschule Esslingen – University of Applied Sciences, Esslingen
› Author Affiliations
Further Information

Publication History

Publication Date:
17 January 2017 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die zu einem pharmakologischen Neuroenhancement (pNE) eingenommenen Substanzen gehen mit gesundheitlichen Risiken und hohen Missbrauchs- und Abhängigkeitspotenzialen einher. Ziel der Analysen war die psychometrische Evaluation der neuen und bisher kaum evaluierten Neuro-Enhancement Attitude Scale (NEAS) mit Bezug auf eine tatsächliche pNE-Anwendung. Mittels einer querschnittlichen Online-Fragebogenstudie wurden Daten über eine studentische Stichprobe (n=787) erhoben und die Studienzeitprävalenz des pNE (3,4%; n=27) erfasst. Es zeigte sich, dass die NEAS über die Variablen Alter, Geschlecht, Konsum koffeinhaltiger Getränke und Alkohol hinaus einen signifikanten Anteil an der Varianz der pNE-Anwendung aufklärt. Die Definition eines Cut-off-Werts ist gegenwärtig zurückzuweisen und eine Weiterentwicklung der NEAS zu empfehlen. Die NEAS bietet eine wichtige Hilfestellung, um frühzeitig auf Präventionsbedarfe hinzuweisen und gezielte Präventionsmaßnahmen entwickeln zu können.

Abstract

Health risks and potential drug abuse and drug dependence are scientific known side effects of pharmacological neuroenhancement (pNE) with prescription drugs and drugs of abuse. Purpose of this study was the psychometric evaluation of the new and up to now little evaluated Neuroenhancement Attitude Scale (NEAS) concerning students’ pNE use. An online cross sectional study was conducted. Analysis was based on a German student sample (n=787). The prevalence of pNE was 3.4% (n=27). Above the effects of age, gender, caffeinated beverages, and alcohol the NEAS explained a significant amount of variance of pNE use. The definition of specific cut-off points has to defer until later because of overlapping distributions. Further developments of the NEAS are recommended. The NEAS could be a useful tool for the early identification of an intervention need and for the development of directed prevention.

Schlüsselwörter

Neuroenhancement - Einstellungen - Studierende - Prävention - Alkohol

Key words

neuroenhancement - attitudes - students - prevention - alcohol
 

  • Literatur

  • 1 Maier LJ, Schaub MP. The Use of Prescription Drugs and Drugs of Abuse for Neuroenhancement in Europe. Eur Psychol 2015; 20: 155-166
    CrossrefPubMedGoogle Scholar
  • 2 Moesgen D, Klein M, Köhler T. et al. Pharmakologisches Neuroenhancement – Epidemiologie und Ursachenforschung. Suchttherapie 2013; 14: 8-15
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Moesgen D, Klein M. Neuroenhancement. 1. Aufl. Stuttgart: Kohlhammer; 2015
    Google Scholar
  • 4 Schröder H, Köhler T, Knerr P. et al. Einfluss psychischer Belastungen am Arbeitsplatz auf das Neuroenhancement – empirische Untersuchungen an Erwerbstätigen. 1. Aufl. Dortmund: Bundesanstalt für Arbeitsschutz und Arbeitsmedizin; 2015
    Google Scholar
  • 5 Franke AG, Bonertz C, Christmann M. et al. Non-Medical Use of Prescription Stimulants and Illicit Use of Stimulants for Cognitive Enhancement in Pupils and Students in Germany. Pharmacopsychiatry 2011; 44: 60-66
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Eickenhorst P, Vitzthum K, Klapp BF. et al. Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. J Psychoactive Drugs 2012; 44: 418-427
    CrossrefPubMedGoogle Scholar
  • 7 Deutsche Angestellten Krankenkasse . DAK-Gesundheitsreport 2015. Hamburg: DAK; 2015
    Google Scholar
  • 8 Forlini C, Schildmann J, Roser P. et al. Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis. Neuroethics 2015; 8: 83-92
    CrossrefPubMedGoogle Scholar
  • 9 Middendorff E, Poskowsky J, Becker K. Formen der Stresskompensation und Leistungssteigerung bei Studierenden. Hannover: DZHW; 2015
    Google Scholar
  • 10 Middendorff E, Poskowsky J, Isserstedt W. Formen der Stresskompensation und Leistungssteigerung bei Studierenden. Hannover: HIS; 2012
    Google Scholar
  • 11 Mache S, Eickenhorst P, Vitzthum K. et al. Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wien Med Wochenschr 2012; 162: 262-271
    CrossrefPubMedGoogle Scholar
  • 12 Sattler S, Mehlkop G, Graeff P. et al. Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Subst Abuse Treat Prev Policy 2014; 9: 8
    CrossrefPubMedGoogle Scholar
  • 13 Sattler S, Wiegel C. Cognitive Test Anxiety and Cognitive Enhancement: The influence of students’ worries on their use of performance-enhancing drugs. Subst Use Misuse 2013; 48: 220-232
    CrossrefPubMedGoogle Scholar
  • 14 Schäffler F, Greim L, Engelfried C. et al. Drogen und Studium – eine quantitative Querschnittsstudie zum Drogenkonsum von Studierenden an der Hochschule München. Suchttherapie 2015; 16: 187-195
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Dietz P, Striegel H, Franke AG. et al. Randomized Response Estimates for the 12-Month Prevalence of Cognitive-Enhancing Drug Use in University Students. Pharmacotherapy 2013; 33: 44-50
    CrossrefPubMedGoogle Scholar
  • 16 Lieb K. Hirndoping. 2. Aufl. Mannheim: Artemis & Winkler; 2010
    Google Scholar
  • 17 Wolff W, Brand R. Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students‘ everyday life “doping”. Subst Abuse Treat Prev Policy 2013; 8: 23
    CrossrefPubMedGoogle Scholar
  • 18 Franke A, Soyka M. Pharmakologisches Neuroenhancement aus Sicht der Suchtmedizin. Fortschr Neurol Psychiatr 2015; 83: 83-90
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Repantis D, Schlattmann P, Laisney O. et al. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res 2010; 62: 187-206
    CrossrefPubMedGoogle Scholar
  • 20 Finger G, Rodrigues da Silva E, Falavigna A. Use of methylphenidate among medical students: a systematic review. Rev Assoc Med Bras 2013; 59: 285-289
    CrossrefPubMedGoogle Scholar
  • 21 Ilieva I, Boland J, Farah MJ. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology 2013; 64: 496-505
    CrossrefPubMedGoogle Scholar
  • 22 Castaldi S, Gelatti U, Orizio G. et al. Use of Cognitive Enhancement Medication among Northern Italian University Students. J Addict Med 2012; 6: 112-117
    CrossrefPubMedGoogle Scholar
  • 23 Franke AG, Lieb K, Hildt E. What Users Think about the Difference between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement. PLoS One 2012; 7: e40047
    CrossrefPubMedGoogle Scholar
  • 24 Müller CP, Schumann G. Drugs as instruments: a new framework for non-addictive psychoactive drug use. Behav Brain Sci 2011; 34: 293-347
    CrossrefPubMedGoogle Scholar
  • 25 Kruglanski AW, Shah JY, Fishbach JA. A Theory of Goal Systems. In: Zanna MP. (ed.). Advances in Experimental Social Psychology. San Diego: Academic Press; 2002. 34: 331-378
    Google Scholar
  • 26 Wolff W, Baumgarten F, Brand R. Reduced self-control leads to disregard of an unfamiliar behavioral option: an experimental approach to the study of neuroenhancement. Subst Abuse Treat Prev Policy 2013; 8: 41
    CrossrefPubMedGoogle Scholar
  • 27 Ajzen I. The Theory of Planned Behavior. Organ Behav Hum Decis Process 1991; 50: 179-211
    CrossrefPubMedGoogle Scholar
  • 28 Petróczi A, Aidman E. Measuring explicit attitude toward doping: Review of the psychometric properties of the Performance Enhancement Attitude Scale. Psychol Sport Exerc 2009; 10: 390-396
    CrossrefPubMedGoogle Scholar
  • 29 Maio GR, Haddock G. Attitude change. In: Kruglanski A, Higgins E. (eds.). Social Psychology: Handbook of Basic Principles. 2nd (ed.). New York: Guilford Press; 2007: 565-586
    Google Scholar
  • 30 Babor TF, Higgins-Biddle JC, Saunders JB. et al. AUDIT. The Alcohol Use Disorders Identification Test. Geneva: WHO; 2001
    Google Scholar
  • 31 Maier LJ, Liechti ME, Herzig F. et al. To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students. PLoS One 2013; 8: e77967
    CrossrefPubMedGoogle Scholar
  • 32 O'Connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer’s MAP test. Behav Res Methods Instrum Comput 2000; 32: 396-402
    CrossrefPubMedGoogle Scholar
  • 33 Cabriales JA, Cooper TV, Taylor T. Prescription Drug Misuse, Illicit Drug Use, and Their Potential Risk and Protective Correlates in a Hispanic College Student Sample. Exp Clin Psychopharmacol 2013; 21: 235-244
    CrossrefPubMedGoogle Scholar
  • 34 Schelle KJ, Faulmüller N, Caviola L. et al. Attitudes towards pharmacological cognitive enhancement – a review. Front in Syst Neurosci 2014; 8: 53
    PubMedGoogle Scholar
  • 35 Ott R, Biller-Andorno N. Neuroenhancement among Swiss Students – A Comparison of Users and Non-Users. Pharmacopsychiatry 2014; 47: 22-28
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Franke AG, Schwarze CE, Christmann M. et al. Charakteristika von Studierenden, die pharmakologisches Neuroenhancement mit Stimulanzien betreiben: Eine Pilotstudie. Psychiat Prax 2012; 39: 174-180
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Franke AG, Hildt E, Lieb K. Muster des Missbrauchs von (Psycho-)Stimulanzien zum pharmakologischen Neuroenhancement bei Studierenden. Suchttherapie 2011; 12: 167-172
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Chan LN, Anderson GD. Pharmacokinetic and Pharmacodynamic Drug Interactions with Ethanol (Alcohol). Clin Pharmacokinet 2014; 53: 1115-1136
    CrossrefPubMedGoogle Scholar
  • 39 Taddicken M. Methodeneffekte von Web-Befragungen: Soziale Erwünschtheit vs. Soziale Entkontextualisierung. In: Weichbold M, Bacher J, Wolf C. (Hrsg.) Umfrageforschung. Wiesbaden: VS Verlag; 2009: 85-104
    CrossrefGoogle Scholar